Researcher finds the new innovation field of each Case Report
The goal of the MedRead Journal of Oncology Research (MedRead J Oncol Res) is to offer scientists, researchers, and other Oncology professionals the opportunity to share knowledge of scientific advancements in the myriad disciplines concerning their work, through an honored peer-reviewed publication. The MedRead Journal of Oncology Research (MedRead J Oncol Res) serves as an international forum for vital research and developments in Oncology.
Journal publishes research articles as full-length research papers, review articles, case reports, short communications, etc. in innovative formats that target a broad and non-specialized audience in all areas of Oncology and making them accessible online freely without any restrictions or any other subscriptions to researchers worldwide.
The field of the journal includes, but is not restricted to:
Programmed Cell Death, Tumor-Associated Inflammation, Chemotherapy, Carcinoma, Esophageal Cancer, Germ cell tumors, Lymphoma, Melanoma, Metastatic Cancer, Sarcoma, Experimental Oncology, Integrative Oncology, Clinical Oncology, Surgical Oncology, Immuno Oncology, Orthopedic Oncology, Oncology Medicine and Practice, Medical Oncology, Cancer Biology, Therapeutic Oncology, Brain Tumors, and Neuro-Oncology, Retinoblastoma, Genitourinary Cancer, Neck Cancer, Skin Cancer, Breast Cancer, Researchers in basic science, etc.
Submission and processing of the manuscripts can be done online into the Editorial Manager System which helps to keep the quality of the peer-review process and presents easy access to the authors to track the status of the manuscript, including evaluation and publication in an automated mode. Subject experts under the guidance of the Editor-in-Chief review the manuscripts. Approval of at least two independent reviewers and the editor is mandatory for the acceptance of the manuscript for publication.